BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27921360)

  • 1. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
    González-Pérez A; Sáez ME; Johansson S; Nagy P; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):215-222. PubMed ID: 27921360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
    García Rodríguez LA; Lin KJ; Hernández-Díaz S; Johansson S
    Circulation; 2011 Mar; 123(10):1108-15. PubMed ID: 21357821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
    González-Pérez A; Sáez ME; Johansson S; Himmelmann A; García Rodríguez LA
    BMC Cardiovasc Disord; 2016 Aug; 16(1):164. PubMed ID: 27577589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel.
    Huang KW; Luo JC; Leu HB; Huang CC; Hou MC; Chen TS; Lu CL; Lin HC; Lee FY; Chang FY
    J Chin Med Assoc; 2013 Jan; 76(1):9-14. PubMed ID: 23331775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
    Lin CC; Hu HY; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1119-28. PubMed ID: 24099473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
    Cea Soriano L; Bueno H; Lanas A; García Rodríguez LA
    Thromb Haemost; 2013 Dec; 110(6):1298-304. PubMed ID: 24008261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
    Lin KJ; De Caterina R; García Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
    Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
    Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom.
    García Rodríguez LA; Lanas A; Soriano-Gabarró M; Cea Soriano L
    Ann Med; 2019 Mar; 51(2):182-192. PubMed ID: 31025592
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
    Luo PJ; Lin XH; Lin CC; Luo JC; Hu HY; Ting PH; Hou MC
    J Formos Med Assoc; 2019 May; 118(5):939-944. PubMed ID: 30366771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
    Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
    Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death.
    Sáez ME; González-Pérez A; Johansson S; Himmelmann A; García Rodríguez LA
    Eur J Prev Cardiol; 2016 Jul; 23(10):1029-36. PubMed ID: 26603743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
    Labos C; Dasgupta K; Nedjar H; Turecki G; Rahme E
    CMAJ; 2011 Nov; 183(16):1835-43. PubMed ID: 21948719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
    Zhang ZF; Sha WH; Tan GY; Wang QY
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):445-50. PubMed ID: 27256606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study.
    Lin XH; Young SH; Luo JC; Peng YL; Chen PH; Lin CC; Chen WM; Hou MC; Lee FY
    Pain Med; 2018 Feb; 19(2):225-231. PubMed ID: 28460044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; Rodríguez LA
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):378-86. PubMed ID: 25501499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.